Fayez Sarofim & Co
BIVV

Fayez Sarofim & Co’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Fayez Sarofim & Co’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,856
Closed -$262K – 254
2017
Q4 		$262K Hold
4,856
– – ﹤0.01% 221
2017
Q3 		$277K Hold
4,856
– – ﹤0.01% 215
2017
Q2 		$292K Hold
4,856
– – ﹤0.01% 215
2017
Q1 		$264K Buy
+4,856
New +$239K ﹤0.01% 223

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Fayez Sarofim & Co's BIVV Position: Q1 2018 in Review

Fayez Sarofim & Co sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 4,856 shares — an estimated $262K sold.

Fayez Sarofim & Co first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $292K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Fayez Sarofim & Co reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Fayez Sarofim & Co sold 4,856 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $262K.
  • Fayez Sarofim & Co first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Fayez Sarofim & Co's Bioverativ Inc. Common Stock position peaked at $292K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Fayez Sarofim & Co's 13F filing for Q1 2018, filed 10 May 2018.